Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine

Abstract excerpt

Extensive studies of the genetic aberrations related to human diseases conducted over the last two decades have identified recurrent genomic abnormalities as potential driving factors underlying a variety of cancers. Over the time, a series of cutting-edge high-throughput genetic tests, such as microarrays and next-generation sequencing, have been developed and incorporated into routine clinical practice....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Chronic Lymphocytic Leukemia Research
• Share to Genomic variations and chromosomal abnormalities